Literature DB >> 5033423

Immune and natural antibodies to syngeneic murine plasma cell tumors.

R B Herberman, T Aoki.   

Abstract

Cytotoxic antibody to a plasma cell tumor antigen was produced in syngeneic BALB mice by immunization with viable or inactivated plasma cell tumors. Antibody with the same specificity was found in the sera of normal BALB and other strains of mice. This natural antibody reacted with an antigen with characteristics indistinguishable from the previously described alloantigen, PC.1, and with viral envelope antigen, chiVEA. The incidence of cytotoxic reactivity and the antibody titers reached a peak in normal BALB mice at 3-4 months of age, and were lower in 9-12-month old mice. The sera of germfree mice had lower reactivity; but when the mice were transferred to conventional conditions, their sera soon became as active as those of conventional mice. A virus common to all plasma cell tumors, which is present in latent form in some normal tissues of BALB and other PC.1 positive strains, is suggested as the cause for the PC.1 antigen and for the appearance of natural antibody to it. The considerable evidence for the close association of a virus with plasma cell tumors is presented.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5033423      PMCID: PMC2139181          DOI: 10.1084/jem.136.1.94

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  29 in total

1.  Induction of plasma-cell neoplasms and fibrosarcomas in BALB/c mice carrying diffusion chambers.

Authors:  R M MERWIN; G H ALGIRE
Journal:  Proc Soc Exp Biol Med       Date:  1959-07

2.  STUDIES OF THIRTY DIFFERENT BENCE JONES PROTEIN-PRODUCING PLASMA CELL NEOPLASMS IN AN INBRED STRAIN OF MOUSE.

Authors:  K R MCINTIRE; M POTTER
Journal:  J Natl Cancer Inst       Date:  1964-10       Impact factor: 13.506

3.  Serological analysis of cell surface antigens of tumors induced by murine leukemia virus.

Authors:  R B Herberman
Journal:  J Natl Cancer Inst       Date:  1972-01       Impact factor: 13.506

4.  The G (Gross) leukemia antigen.

Authors:  L J Old; E A Boyse; E Stockert
Journal:  Cancer Res       Date:  1965-07       Impact factor: 12.701

5.  Prolonged adjuvant stimulation in germ-free BALB-c mice: development of plasma cell neoplasia.

Authors:  K R McIntire; G L Princler
Journal:  Immunology       Date:  1969-09       Impact factor: 7.397

6.  The extraction of intracisternal A-particles from a mouse plasma-cell tumor.

Authors:  E L Kuff; N A Wivel; K K Lueders
Journal:  Cancer Res       Date:  1968-10       Impact factor: 12.701

7.  Surface alloantigens of plasma cells.

Authors:  T Takahashi; L J Old; E A Boyse
Journal:  J Exp Med       Date:  1970-06-01       Impact factor: 14.307

8.  Oncogenes of RNA tumor viruses as determinants of cancer.

Authors:  R J Huebner; G J Todaro
Journal:  Proc Natl Acad Sci U S A       Date:  1969-11       Impact factor: 11.205

9.  Leukemia viruses associated with mouse myeloma cells.

Authors:  J Watson; P Ralph; S Sarkar; M Cohn
Journal:  Proc Natl Acad Sci U S A       Date:  1970-06       Impact factor: 11.205

10.  Viral and cellular surface antigens of murine leukemias and myelomas. Serological analysis by immunoelectron microscopy.

Authors:  T Aoki; T Takahashi
Journal:  J Exp Med       Date:  1972-03-01       Impact factor: 14.307

View more
  10 in total

1.  Normal human IgG with antibody activity for keyhole limpet haemocyanin.

Authors:  L A Moroz; V Krygier; A O Kotoulas
Journal:  Immunology       Date:  1973-09       Impact factor: 7.397

2.  Interspecies brain antigen detected by naturally occurring mouse anti-brain autoantibody.

Authors:  S E Martin; W J Martin
Journal:  Proc Natl Acad Sci U S A       Date:  1975-03       Impact factor: 11.205

3.  Genetic control of resistance to tumors.

Authors:  J M Phillips-Quagliata; M C Walker
Journal:  Am J Pathol       Date:  1978-11       Impact factor: 4.307

4.  Type C virus and immunoglobulin A production by murine myeloma MOPC-315: two independent activities.

Authors:  A Gazit; A Yaniv; D Halperin; S Ben-Efraim
Journal:  Infect Immun       Date:  1979-08       Impact factor: 3.441

5.  Quantitative studies of the growth and rejection of allogeneic tumour cells in mouse cerebrospinal fluid. Elimination in the absence of H-2 differences.

Authors:  P C Doherty; R M Zinkernagel
Journal:  Clin Exp Immunol       Date:  1975-02       Impact factor: 4.330

6.  Depression of alloantigens in malignancy. Evidence for tumour susceptibility alloantigens and for possible self-reactivity of lymphoid cells active in the microcytotoxicity assay.

Authors:  W J Martin; E Esber; W G Cotton; J M Rice
Journal:  Br J Cancer Suppl       Date:  1973-08

7.  Antigenic properties of endogenous type-C viruses from spontaneously transformed clones of BALB-3T3.

Authors:  T Aoki; G J Todaro
Journal:  Proc Natl Acad Sci U S A       Date:  1973-05       Impact factor: 11.205

8.  Presence of a tumour-inhibiting factor (TIF) in sera from normal but not tumour-bearing mice.

Authors:  B S Kim; D K Chin
Journal:  Immunology       Date:  1980-10       Impact factor: 7.397

9.  Regulation of immune responses against the syngeneic ADJ-PC-5 plasmacytoma in BALB/c mice. I. Analysis of immune parameters involved.

Authors:  J Cihak; H W Ziegler; E Kölsch
Journal:  Immunology       Date:  1981-05       Impact factor: 7.397

10.  Naturally occurring lymphocyte-mediated immunity to endogenous type-C virus in the mouse. Blocking of the lymphocyte reactivity with antisera to the virus.

Authors:  M Kende; R Hill; M Dinowitz; J R Stephenson; G J Kelloff
Journal:  J Exp Med       Date:  1979-02-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.